{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
PetMed Express, Inc.
PetMed Express Hits 52-Week Low at $2.71 Amidst Yearly Decline
PetMed Express, Inc. has hit a new 52-week low, reflecting a notable decline in its stock value over the past year. The company, with a market cap of USD 59 million, shows a strong balance sheet but low return on equity. Despite recent challenges, it has achieved significant profit growth.
Is PetMed Express, Inc. technically bullish or bearish?
As of September 8, 2025, PetMed Express, Inc. is in a bearish trend with weak momentum, reflected by bearish MACD and moving averages, and has significantly underperformed the S&P 500 with a year-to-date return of -41.91%.
Is PetMed Express, Inc. overvalued or undervalued?
As of May 21, 2025, PetMed Express, Inc. is fairly valued with a P/E ratio of 82, lagging behind peers like Build-A-Bear Workshop at 12.51, and has underperformed the S&P 500 with a year-to-date return of -32.37%.
Is PetMed Express, Inc. technically bullish or bearish?
As of June 11, 2025, PetMed Express, Inc. is in a mildly bearish trend, indicated by bearish momentum from the weekly MACD and daily moving averages, despite some mildly bullish signals on monthly indicators.
Who are in the management team of PetMed Express, Inc.?
As of March 2022, the management team of PetMed Express, Inc. includes Mr. Robert Schweitzer (Independent Chairman), Mr. Menderes Akdag (President and CEO), and five independent directors: Ms. Leslie Campbell, Mr. Frank Formica, Dr. Gian Fulgoni, and Mr. Ronald Korn. They oversee the company's operations and strategic direction.
What does PetMed Express, Inc. do?
PetMed Express, Inc. (1800PetMeds) is a pet pharmacy that sells prescription and non-prescription medications and health products for dogs and cats. As of December 2024, it reported net sales of $53 million and a net profit of -$1 million, with a market cap of $72.09 million.
How big is PetMed Express, Inc.?
As of Jun 18, PetMed Express, Inc. has a market capitalization of 72.09 million, with net sales of 247.00 million and a net profit of 0.35 million over the last four quarters. Shareholder's funds are reported at 96.73 million, and total assets amount to 175.09 million as of Mar 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
